|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 45/06 | (nenurodyta) |
| A61K 9/20 | (nenurodyta) | ||
| A61K 9/16 | (nenurodyta) | ||
| A61K 9/14 | (nenurodyta) | ||
| C07D 209/04 | (nenurodyta) | ||
| C07D 215/00 | (nenurodyta) | ||
| A61K 31/47 | (nenurodyta) | ||
| A61K 31/404 | (nenurodyta) | ||
| A61K 31/443 | (nenurodyta) | ||
| A61K 31/4709 | (nenurodyta) | ||
| A61K 31/4725 | (nenurodyta) | ||
| C07D 215/56 | (nenurodyta) | ||
| C07D 405/12 | (nenurodyta) | ||
| A61P 11/00 | (nenurodyta) | ||
| A61P 43/00 | (nenurodyta) |
| (11) | Number of the document | 3131582 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15721912.2 |
| Date of filing the European patent application | 2015-04-14 | |
| (97) | Date of publication of the European application | 2017-02-22 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-23 |
| (46) | Date of publication of the claims translation | 2018-10-25 |
| (86) | Number | PCT/US2015/025722 |
| Date | 2015-04-14 |
| (87) | Number | WO 2015/160787 |
| Date | 2015-10-22 |
| (30) | Number | Date | Country code |
| 201461979848 P | 2014-04-15 | US | |
| 201462059287 P | 2014-10-03 | US |
| (72) |
PHENIX, Brian Dean, US
BAGNOL, Laurent Jean-claude, US
BRODEUR, Geoffrey Glen, US
CHANDRAN, Sachin, US
DOKOU, Eleni, US
FERRIS, Lori Ann, US
KNEZIC, Dragutin, US
MCCARTY, Katie Lynn, US
MEDEK, Ales, US
WAGGENER, Sara A., US
|
| (73) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, Boston, MA 02210,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Farmacinės kompozicijos, skirtos cistinės fibrozės transmembraninio laidumo reguliatorių sukeltų ligų gydymui |
| PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MEDIATED DISEASES |
| Payment date | Validity (years) | Amount | |
| 2025-03-18 | 11 | 289.00 EUR |
| 2026-04-14 |